Table 2.
Variable | P value |
Recipient factors | |
Age (yr) | 0.942 |
Sex (male/female) | 0.410 |
MELD score | 0.150 |
Child-Pugh score | 0.754 |
GRWR (%) | 0.545 |
ABO-compatibility | 0.185 |
2001-2005/2006-2010 | 0.634 |
ICU stay (h) | 0.065 |
Hospitalization time (d) | 0.868 |
Pre-transplant complications | |
Encephalopathy | 0.688 |
GI bleeding | 0.688 |
Peritonitis | - |
Uncontrolled ascites | 0.563 |
Renal insufficiency | - |
Etiology | |
Hepatic malignancy | - |
Viral cirrhosis | - |
Non-viral cirrhosis | - |
Cholestasis | - |
Acute liver failure | - |
Other | - |
Donor factors | |
Age (yr) | 0.094 |
Sex (male/female) | 0.201 |
Body mass index | 0.253 |
Relationship | 0.537 |
Operative factors | |
Operative time (min) | 0.245 |
Blood loss (mL) | 0.310 |
Ahepatic duration (min) | 0.605 |
MHV tributary drainage1 | 0.064 |
Concurrent splenectomy | 0.358 |
Types of biliary reconstruction2 | 0.730 |
Complications after LDLT | |
Postoperative bleeding | 0.730 |
Acute rejection | 0.730 |
Vascular complications | 0.730 |
Biliary complications | 0.469 |
SFSS | < 0.001a |
Middle hepatic vein (MHV) tributary drainage includes MHV tributary reconstruction and MHV trunk inclusion;
Types of biliary reconstruction type includes duct-to-duct anastomosis and Roux-en-Y hepaticojejunostomy. LDLT: Living donor liver transplantation; MELD: Model for end-stage liver disease; GRWR: Graft-to-recipient weight ratio; GI: Gastrointestinal; ICU: Intensive care unit.
P < 0.05.